HER4(ErbB4)激酶综述:其对癌症的影响及其抑制剂。
A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors.
机构信息
College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates.
Sharjah Institute for Medical Research, University of Sharjah, Sharjah 27272, United Arab Emirates.
出版信息
Molecules. 2021 Dec 5;26(23):7376. doi: 10.3390/molecules26237376.
HER4 is a receptor tyrosine kinase that is required for the evolution of normal body systems such as cardiovascular, nervous, and endocrine systems, especially the mammary glands. It is activated through ligand binding and activates MAPKs and PI3K/AKT pathways. HER4 is commonly expressed in many human tissues, both adult and fetal. It is important to understand the role of HER4 in the treatment of many disorders. Many studies were also conducted on the role of HER4 in tumors and its tumor suppressor function. Mostly, overexpression of HER4 kinase results in cancer development. In the present article, we reviewed the structure, location, ligands, physiological functions of HER4, and its relationship to different cancer types. HER4 inhibitors reported mainly from 2016 to the present were reviewed as well.
HER4 是一种受体酪氨酸激酶,对于心血管、神经和内分泌等正常身体系统的发育,特别是乳腺的发育是必需的。它通过配体结合激活 MAPKs 和 PI3K/AKT 通路。HER4 通常在许多成人和胎儿的人体组织中表达。了解 HER4 在许多疾病治疗中的作用非常重要。许多研究还探讨了 HER4 在肿瘤中的作用及其肿瘤抑制功能。HER4 激酶的过度表达主要导致癌症的发生。在本文中,我们综述了 HER4 的结构、位置、配体、生理功能及其与不同癌症类型的关系。还综述了 2016 年至今报道的 HER4 抑制剂。